IN8bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.About INAB
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S.
CEOWilliam T. Ho
CEOWilliam T. Ho
Employees18
Employees18
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2016
Founded2016
Employees18
Employees18
INAB Key Statistics
Market cap7.37M
Market cap7.37M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume83.59K
Average volume83.59K
High today$1.70
High today$1.70
Low today$1.57
Low today$1.57
Open price$1.59
Open price$1.59
Volume43.28K
Volume43.28K
52 Week high$12.53
52 Week high$12.53
52 Week low$1.53
52 Week low$1.53
Stock Snapshot
IN8bio(INAB) stock is priced at $1.58, giving the company a market capitalization of 7.37M. It carries a P/E multiple of -0.24.
On 2025-11-15, IN8bio(INAB) stock moved within a range of $1.57 to $1.70. With shares now at $1.58, the stock is trading +0.3% above its intraday low and -7.1% below the session's peak.
Trading activity shows a volume of 43.28K, compared to an average daily volume of 83.59K.
The stock's 52-week range extends from a low of $1.53 to a high of $12.53.
The stock's 52-week range extends from a low of $1.53 to a high of $12.53.
People also own
Based on the portfolios of people who own INAB. This list is generated using Robinhood data, and it’s not a recommendation.